Archive

The panel discussion on Overseas Listing – Insights for Corporates took place on Monday, 23 November 2020. The second conversation of the webinar series was focused on high-growth mid-market companies that have explored the overseas listing opportunity or are interested in knowing more about overseas listing.

Key Highlights

• Companies with global aspirations and well-defined strategies for growth should consider listing overseas. Healthcare, pharma, cleantech and biotech companies will be among the early drivers of overseas listing.
• Understanding the process and choosing the right partners is key to achieving a successful listing. Advisors provide the right direction in terms of roadshows, due diligence checks and regulatory compliances.
• While overseas listing provides flexibility, there are strict governance and compliance requirements to be adhered to.
• Knowing your investors and the market for your business are crucial factors for choosing the exchange for listing.

Speakers

Vishesh C. Chandiok CEO Grant Thornton Bharat	Keshav R. Murugesh (keynote) Group CEO WNS Global Services, Past Chairman, NASSCOM	Robert H. McCooey, Jr. Chairman, Asia Pacific NASDAQ	Gokul Mani Head of Primary Markets – Middle East, Africa & India London Stock Exchange (LSE)	Bharat K. Reddy JPMorgan Chase & Co.
Francis Giglio MD & Head, Depositary Receipts – APAC, Hong Kong BNY Mellon	Rajiv Gupta Partner Latham & Watkins LLP, Singapore	Sanjay Banthia Chartered Accountant, Mumbai	Raja Lahiri Partner Grant Thornton Bharat	Prashant Mehra (moderator) Partner Grant Thornton Bharat

If you are interested in exploring the overseas listing opportunity for your organisation, or have any questions, please email our expert at Raja.Lahiri@IN.GT.COM